MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Can Fite Biopharma Ltd Company Profile (NASDAQ:CANF)

Consensus Ratings for Can Fite Biopharma Ltd (NASDAQ:CANF) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.20 (46.12% upside)

Analysts' Ratings History for Can Fite Biopharma Ltd (NASDAQ:CANF)
Show:
DateFirmActionRatingPrice TargetActions
5/3/2015HC WainrightReiterated RatingBuy$3.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015HC WainrightLower Price TargetBuy$7.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Roth CapitalDowngradeBuy -> Neutral$20.00 -> $2.40View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Roth CapitalSet Price TargetBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2014Roth CapitalLower Price TargetBuy$28.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014HC WainrightInitiated CoverageBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2013Roth CapitalBoost Price Target$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2013 forward)